Concepedia

Katharina Bergerhoff

KB

9

Publications

2.1K

Citations

9

H-Index

2011

Active since

Affiliations

University College London(Current)

Institute of Cancer Research

London Cancer

Memorial Sloan Kettering Cancer Center

Royal Marsden Hospital

Katharina Bergerhoff is an author at University College London specializing in tumor biology, tumor immunity, and immune regulation.

ORCID

Top concepts

Publications per year

2011–2020

9

Publications

9

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz et al. · The Journal of Experimental Medicine · 2013 · 1.4K citations · Full text

Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells

Anna Śledzińska, Maria Vila de Mucha, Katharina Bergerhoff et al. · Immunity · 2020 · 215 citations · Full text

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

Magnus T. Dillon, Katharina Bergerhoff, Malin Pedersen et al. · Clinical Cancer Research · 2019 · 200 citations

TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors

Laurie Menger, Anna Śledzińska, Katharina Bergerhoff et al. · Cancer Research · 2016 · 78 citations · Full text

, , +19

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

Laurie Menger, Agnès Gouble, Maria A. V. Marzolini et al. · Blood · 2015 · 58 citations

Rows per page

1–5 of 9